Literature DB >> 1973444

Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.

R J Melder1, E R Walker, R B Herberman, T L Whiteside.   

Abstract

Human adherent lymphokine-activated killer (A-LAK) cells represent a population of highly cytotoxic, interleukin-2 (IL-2)-activated peripheral blood lymphocytes that have large granular lymphocyte (LGL) morphology and display natural killer (NK) cell-associated surface markers (CD3-CD56+). The ultrastructure of A-LAK cells also is consistent with that of highly activated NK cells. After their initial isolation, continued culture of A-LAK cells in the presence of IL-2 resulted in cyclic shifts between adherent and non-adherent phases with about 90% of the cells floating and non-adherent. All of these A-LAK cells were spheroidal with numerous villi and pseudopodia. In the adherent phase, A-LAK cells were motile, moving along the solid surface at a speed of about 1 micron per minute, and polar, with a ruffled leading edge at one end of the cell and a terminal tuft of villi at the opposite end. Transmission electron microscopy of these cells also demonstrated a high degree of internal polarity, with the nucleus at the leading edge of the cell and richly granulated cytoplasm at the terminal end. Extensive cytoskeletal structures, multivesicular bodies, and an active Golgi complex characterized these cells. A-LAK cells in the adherent phase were found to express numerous point contacts (podosomes) and larger adherence structures containing polymerized actin, which appear to be important for interactions of these cells with the substrate. Increased expression of adhesion molecules in association with surface structures mediating adherence is also responsible for effective binding of A-LAK cells to solid surfaces.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973444     DOI: 10.1002/jlb.48.2.163

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

Review 1.  Importance of RhoGTPases in formation, characteristics, and functions of invadosomes.

Authors:  Pirjo Spuul; Paolo Ciufici; Véronique Veillat; Anne Leclercq; Thomas Daubon; IJsbrand Kramer; Elisabeth Génot
Journal:  Small GTPases       Date:  2014-05-08

2.  Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells.

Authors:  Christine Varon; Florence Tatin; Violaine Moreau; Ellen Van Obberghen-Schilling; Samantha Fernandez-Sauze; Edith Reuzeau; Ijsbrand Kramer; Elisabeth Génot
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

3.  Use of recombinant interleukin-2 to enhance adoptive transfer of resistance to Listeria monocytogenes infection.

Authors:  M Haak-Frendscho; C J Czuprynski
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Cryopreserved NK cells in the treatment of haematological malignancies: preclinical study.

Authors:  Monika Holubova; Michaela Miklikova; Martin Leba; Daniel Georgiev; Pavel Jindra; Martin Caprnda; Rachele Ciccocioppo; Peter Kruzliak; Daniel Lysak
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-10       Impact factor: 4.553

5.  Kinetics of interleukin-2 induced changes in rigidity of human natural killer cells.

Authors:  R J Melder; R K Jain
Journal:  Cell Biophys       Date:  1992 Apr-Jun

6.  High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells.

Authors:  J Koberda; L Bergmann; P S Mitrou; D Hoelzer
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.

Authors:  P J Kuppen; A M Eggermont; K M Smits; J D van Eendenburg; S P Lazeroms; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

8.  Trafficking of activated lymphocytes into the RENCA tumour microcirculation in vivo in mice.

Authors:  N J Brown; S Ali; M W Reed; R Wiltrout; R C Rees
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 9.  "Adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy.

Authors:  Senthamil R Selvan; John P Dowling
Journal:  Biomed Res Int       Date:  2015-06-16       Impact factor: 3.411

10.  Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii.

Authors:  C S Subauste; L Dawson; J S Remington
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.